Unlike signature A tumors, the signature B CNA patterns were quite distinct between tumor types, although some commonalities were observed including point mutations in oncogenes such as KRAS (LU and UCEC) and amplification of MYC (BRCA, LU, and OV). This evidence concerns the gene KRAS and neoplasm.